Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 2, 2011, Pages

  Zhang, Dongjuan ^a,b   Yang, Hang ^a,b   Kong, Xiaomu ^a,b   Wang, Kang ^a   Mao, Xuan ^d   Yan, Xianzhong ^d   Wang, Yuan ^c   Liu, Siqi ^c   Zhang, Xiaoyan ^a,b   Li, Jing ^a,b   Wu, Jing ^a,b   Wei, Mingfen ^a,b   Yang, Jichun ^a,b   Guan, Youfei ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

Author keywords

Diabetic nephropathy; Epithelial tomesenchymal transition; Gene expression; Ketone body

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 3 HYDROXY 3 METHYLGLUTARYL COENZYME A SYNTHASE 2; 3 HYDROXYBUTYRIC ACID; COLLAGEN TYPE 1; ENZYME; KETONE BODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EPITHELIAL MESENCHYMAL TRANSITION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KETOGENESIS; KIDNEY; KIDNEY PROXIMAL TUBULE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR MECHANICS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; TWO DIMENSIONAL ELECTROPHORESIS;

3-HYDROXYBUTYRIC ACID; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGEN TYPE I; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EPITHELIUM; FLUORESCENT ANTIBODY TECHNIQUE; HYDROXYMETHYLGLUTARYL-COA SYNTHASE; IMMUNOHISTOCHEMISTRY; KETONE BODIES; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES, PROXIMAL; MESODERM; MICE; MICE, INBRED C57BL; PROTEOMICS; RATS; RNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79251586531     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00308.2010     Document Type: Article

References (50)

1. Allen TJ, Cooper ME, Lan HY. Use of genetic mouse models in the study of diabetic nephropathy. Curr Diab Rep 4: 435-440, 2004. (Pubitemid 40104219)
2. Barati MT, Merchant ML, Kain AB, Jevans AW, McLeish KR, Klein JB. Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice. Am J Physiol Renal Physiol 293: F1157-F1165, 2007.
3. Begriche K, Letteron P, Abbey-Toby A, Vadrot N, Robin MA, Bado A, Pessayre D, Fromenty B. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice. Am J Physiol Endocrinol Metab 294: E939-E951, 2008.
4. Breyer MD, Bottinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K. Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005.
5. Cha DR, Zhang X, Zhang Y, Wu J, Su D, Han JY, Fang X, Yu B, Breyer MD, Guan Y. Peroxisome proliferator activated receptor alpha/ gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes 56: 2036-2045, 2007.
6. 1H NMR spectroscopy of blood plasma metabolites. Anal Chem 75: 2100-2104, 2003.
7. Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4: 444-452, 2008.
8. Ferrier B, Martin M, Janbon B, Baverel G. Transport of β-hydroxybutyrate and acetoacetate along rat nephrons: a micropuncture study. Am J Physiol Renal Physiol 262: F762-F769, 1992.
9. Guh JY, Chuang TD, Chen HC, Hung WC, Lai YH, Shin SJ, Chuang LY. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3. Kidney Int 64: 2041-2051, 2003.
10. Hegardt FG. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem J 338: 569-582, 1999.
11. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003.
12. Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16: 1034-1059, 1995.
13. Konig B, Koch A, Giggel K, Dordschbal B, Eder K, Stangl GI. Monocarboxylate transporter (MCT)-1 is up-regulated by PPARalpha. Biochim Biophys Acta 1780: 899-904, 2008.
14. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15: 412-426, 1999.
15. Lascelles CV, Quant PA. Investigation of human hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase in postmortem or biopsy tissue. Clin Chim Acta 260: 85-96, 1997.
16. Li N, Guo R, Li W, Shao J, Li S, Zhao K, Chen X, Xu N, Liu S, Lu Y. A proteomic investigation into a human gastric cancer cell line BGC823 treated with diallyl trisulfide. Carcinogenesis 27: 1222-1231, 2006.
17. Mascaro C, Buesa C, Ortiz JA, Haro D, Hegardt FG. Molecular cloning and tissue expression of human mitochondrial 3-hydroxy-3-methylglutaryl- CoA synthase. Arch Biochem Biophys 317: 385-390, 1995.
18. Mauer SM, Lane P, Hattori M, Fioretto P, Steffes MW. Renal structure and function in insulin-dependent diabetes mellitus and type I membrano- proliferative glomerulonephritis in humans. J Am Soc Nephrol 2: S181-S184, 1992.
19. Mauer SM, Lane P, Zhu D, Fioretto P, Steffes MW. Renal structure and function in insulin-dependent diabetes mellitus in man. J Hypertens Suppl 10: S17-S20, 1992.
20. Meertens LM, Miyata KS, Cechetto JD, Rachubinski RA, Capone JP. A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARalpha. EMBO J 17: 6972-6978, 1998.
21. Merchant ML, Klein JB. Proteomics and diabetic nephropathy. Curr Diab Rep 5: 464-469, 2005.
22. Miao J, Fan Q, Cui Q, Zhang H, Chen L, Wang S, Guan N, Guan Y, Ding J. Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes. Nephrol Dial Transplant 24: 3297-3305, 2009.
23. Nadal A, Marrero PF, Haro D. Down-regulation of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by insulin: the role of the forkhead transcription factor FKHRL1. Biochem J 366: 289-297, 2002.
24. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021, 1975.
25. Ortiz JA, Gil-Gomez G, Casaroli-Marano RP, Vilaro S, Hegardt FG, Haro D. Transfection of the ketogenic mitochondrial 3-hydroxy-3-methylglutaryl- coenzyme A synthase cDNA into Mev-1 cells corrects their auxotrophy for mevalonate. J Biol Chem 269: 28523-28526, 1994.
26. Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker HC, Knowler WC, Monroy M, Libermann TA, Karumanchi SA, Thadhani R. Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 30: 638-643, 2007.
27. Perkins BA, Aiello LP, Krolewski AS. Diabetes complications and the renin-angiotensin system. N Engl J Med 361: 83-85, 2009.
28. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55: 2502-2509, 2006.
29. Quant PA, Robin D, Robin P, Ferre P, Brand MD, Girard J. Control of hepatic mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase during the foetal/neonatal transition, suckling and weaning in the rat. Eur J Biochem 195: 449-454, 1991.
30. Quant PA, Tubbs PK, Brand MD. Treatment of rats with glucagon or mannoheptulose increases mitochondrial 3-hydroxy-3-methylglutaryl- CoA synthase activity and decreases succinyl-CoA content in liver. Biochem J 262: 159-164, 1989.
31. Reeves WB, Andreoli TE. Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 97: 7667-7669, 2000.
32. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16: 667-675, 2005.
33. Rossing K, Mischak H, Dakna M, Zurbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P. Urinary proteomics in diabetes and CKD. J Am Soc Nephrol 19: 1283-1290, 2008.
34. Sarafidis PA, Bakris GL. Protection of the kidney by thiazolidinediones: an assessment from bench to bedside. Kidney Int 70: 1223-1233, 2006.
35. Schleicher E, Kolm V, Ceol M, Nerlich A. Structural and functional changes in diabetic glomerulopathy. Kidney Blood Press Res 19: 305-315, 1996.
36. Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996.
37. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284: F1138-F1144, 2003.
38. Simonson MS. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int 71: 846-854, 2007.
39. Soldatos G, Cooper ME. Diabetic nephropathy: important pathophysiologic mechanisms. Diab Res Clin Pract 82, Suppl 1: S75-S79, 2008.
40. Thongboonkerd V, Barati MT, McLeish KR, Benarafa C, Remold- O'Donnell E, Zheng S, Rovin BH, Pierce WM, Epstein PN, Klein JB. Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol 15: 650-662, 2004.
41. Thongboonkerd V, Zheng S, McLeish KR, Epstein PN, Klein JB. Proteomic identification and immunolocalization of increased renal calbindin- D28k expression in OVE26 diabetic mice. Rev Diabet Stud 2: 19-26, 2005.
42. Thumelin S, Forestier M, Girard J, Pegorier JP. Developmental changes in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression in rat liver, intestine and kidney. Biochem J 292: 493-496, 1993.
43. Tilton RG, Haidacher SJ, Lejeune WS, Zhang X, Zhao Y, Kurosky A, Brasier AR, Denner L. Diabetes-induced changes in the renal cortical proteome assessed with two-dimensional gel electrophoresis and mass spectrometry. Proteomics 7: 1729-1742, 2007.
44. Valera A, Pelegrin M, Asins G, Fillat C, Sabater J, Pujol A, Hegardt FG, Bosch F. Overexpression of mitochondrial 3-hydroxy-3-methylglutaryl- CoA synthase in transgenic mice causes hepatic hyperketogenesis. J Biol Chem 269: 6267-6270, 1994.
45. Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, Chua S, Levi M. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 54: 2328-2335, 2005.
46. Yang J, Gao Z, Robert CE, Burkhardt BR, Gaweska H, Wagner A, Wu J, Greene SR, Young RA, Wolf BA. Structure-function studies of PANDER, an islet specific cytokine inducing cell death of insulin-secreting beta cells. Biochemistry 44: 11342-11352, 2005.
47. Yang J, Robert CE, Burkhardt BR, Young RA, Wu J, Gao Z, Wolf BA. Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells. Diabetes 54: 3217-3228, 2005.
48. Yoshida Y, Miyazaki K, Kamiie J, Sato M, Okuizumi S, Kenmochi A, Kamijo K, Nabetani T, Tsugita A, Xu B, Zhang Y, Yaoita E, Osawa T, Yamamoto T. Two-dimensional electrophoretic profiling of normal human kidney glomerulus proteome and construction of an extensible markup language (XML)-based database. Proteomics 5: 1083-1096, 2005. (Pubitemid 40469037)
49. Zheng F, Guan Y. Thiazolidinediones: a novel class of drugs for the prevention of diabetic nephropathy? Kidney Int 72: 1301-1303, 2007.
50. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000. (Pubitemid 30460765)